Rowlands J, Heng J, Newsholme P, Carlessi R
The cost of manufacturing GLP-1 anti-obesity drugs is low April 10, 2024 Source: Barber, MJ et al JAMA Network Open March 27, 2024 LINK (Calculated from the Appendix eTable 1 and eFigure 1, assuming the highest cost pens ($2.50 each) and doubling cost of API to account for wastage) New information about the potential medical benefits of GLP-1 medications tantalizes us
And what should be a straightforward medical conversation turns into an awkward exchange that ends with "let us try diet and exercise first." That frustration is real
GLP-1 patches are an emerging technology being studied as an alternative to injectable GLP-1 receptor agonists, which are medications commonly prescribed for type 2 diabetes and weight management
The Geography of the GLP-1 Divide The states bearing the nation's heaviest burden of obesity are also the ones where GLP medications consume the largest share of income
Theres no tapering-off regimen either, but thats true about many other medications, he notes
